{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:51:26Z","timestamp":1793641886102,"version":"4.5.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC2703104"],"award-info":[{"award-number":["2022YFC2703104"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071839"],"award-info":[{"award-number":["82071839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["823B2037"],"award-info":[{"award-number":["823B2037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271848"],"award-info":[{"award-number":["82271848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232113"],"award-info":[{"award-number":["7232113"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High-Level Hospital Clinical Research Funding","award":["2022-PUMCH-C-006"],"award-info":[{"award-number":["2022-PUMCH-C-006"]}]},{"name":"National High-Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-013"],"award-info":[{"award-number":["2022-PUMCH-B-013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10067-025-07749-6","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:29:22Z","timestamp":1761114562000},"page":"4985-4994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["IgG4-related disease with comorbid autoimmune diseases: a retrospective study from a large cohort"],"prefix":"10.1007","volume":"44","author":[{"given":"Xinli","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxie","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingna","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-3495","authenticated-orcid":false,"given":"Jiaxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-9867","authenticated-orcid":false,"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"7749_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","volume":"16","author":"CA Perugino","year":"2020","unstructured":"Perugino CA, Stone JH (2020) IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16:702\u2013714. https:\/\/doi.org\/10.1038\/s41584-020-0500-7","journal-title":"Nat Rev Rheumatol"},{"key":"7749_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/ard-2023-223950","volume":"82","author":"ZS Wallace","year":"2023","unstructured":"Wallace ZS, Miles G, Smolkina E et al (2023) Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults. Ann Rheum Dis 82:957\u2013962. https:\/\/doi.org\/10.1136\/ard-2023-223950","journal-title":"Ann Rheum Dis"},{"key":"7749_CR3","doi-asserted-by":"publisher","first-page":"1251134","DOI":"10.3389\/fimmu.2023.1251134","volume":"14","author":"R Kersten","year":"2023","unstructured":"Kersten R, Trampert DC, Hubers LM et al (2023) Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids. Front Immunol 14:1251134. https:\/\/doi.org\/10.3389\/fimmu.2023.1251134","journal-title":"Front Immunol"},{"key":"7749_CR4","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","volume":"402","author":"G Schett","year":"2023","unstructured":"Schett G, Mackensen A, Mougiakakos D (2023) CAR T-cell therapy in autoimmune diseases. Lancet Lond Engl 402:2034\u20132044. https:\/\/doi.org\/10.1016\/S0140-6736(23)01126-1","journal-title":"Lancet Lond Engl"},{"key":"7749_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1272084","volume":"15","author":"RV Motta","year":"2024","unstructured":"Motta RV, Culver EL (2024) IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease. Front Immunol 15:1272084. https:\/\/doi.org\/10.3389\/fimmu.2024.1272084","journal-title":"Front Immunol"},{"key":"7749_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejim.2023.03.015","volume":"111","author":"V Batani","year":"2023","unstructured":"Batani V, Lanzillotta M, Mahajne J et al (2023) Association of IgG4-related disease and systemic rheumatic disorders. Eur J Intern Med 111:63\u201368. https:\/\/doi.org\/10.1016\/j.ejim.2023.03.015","journal-title":"Eur J Intern Med"},{"key":"7749_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejim.2023.08.014","volume":"117","author":"G Hern\u00e1ndez-Molina","year":"2023","unstructured":"Hern\u00e1ndez-Molina G, Mart\u00edn-Nares E (2023) Polyautoimmunity in IgG4-related disease. Eur J Intern Med 117:144\u2013145. https:\/\/doi.org\/10.1016\/j.ejim.2023.08.014","journal-title":"Eur J Intern Med"},{"key":"7749_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000680","volume":"94","author":"D Inoue","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N et al (2015) IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 94:e680. https:\/\/doi.org\/10.1097\/MD.0000000000000680","journal-title":"Medicine (Baltimore)"},{"key":"7749_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002865","volume":"9","author":"R Sun","year":"2023","unstructured":"Sun R, Liu Z, Lu H et al (2023) Potential impact of autoimmune diseases family history in IgG4-related disease: a retrospective cohort study. RMD Open 9:e002865. https:\/\/doi.org\/10.1136\/rmdopen-2022-002865","journal-title":"RMD Open"},{"key":"7749_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","volume":"72","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S et al (2020) The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 72:7\u201319. https:\/\/doi.org\/10.1002\/art.41120","journal-title":"Arthritis Rheumatol"},{"key":"7749_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","volume":"31","author":"H Umehara","year":"2021","unstructured":"Umehara H, Okazaki K, Kawa S et al (2021) The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 31:529\u2013533. https:\/\/doi.org\/10.1080\/14397595.2020.1859710","journal-title":"Mod Rheumatol"},{"key":"7749_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","volume":"81","author":"JC Robson","year":"2022","unstructured":"Robson JC, Grayson PC, Ponte C et al (2022) 2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis 81:315\u2013320. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221795","journal-title":"Ann Rheum Dis"},{"key":"7749_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R et al (2011) The assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25\u201331. https:\/\/doi.org\/10.1136\/ard.2010.133645","journal-title":"Ann Rheum Dis"},{"key":"7749_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Landew\u00e9 R, van der Heijde D et al (2009) The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770\u2013776. https:\/\/doi.org\/10.1136\/ard.2009.108217","journal-title":"Ann Rheum Dis"},{"key":"7749_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR (2014) Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 13:391\u2013397. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.007","journal-title":"Autoimmun Rev"},{"key":"7749_CR16","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/hep.32117","volume":"75","author":"KD Lindor","year":"2022","unstructured":"Lindor KD, Bowlus CL, Boyer J et al (2022) Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases. Hepatology 75:1012\u20131013. https:\/\/doi.org\/10.1002\/hep.32117","journal-title":"Hepatology"},{"key":"7749_CR17","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","volume":"64","author":"RIG Holt","year":"2021","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A et al (2021) The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 64:2609\u20132652. https:\/\/doi.org\/10.1007\/s00125-021-05568-3","journal-title":"Diabetologia"},{"key":"7749_CR18","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1111\/jdv.19451","volume":"37","author":"N van Geel","year":"2023","unstructured":"van Geel N, Speeckaert R, Ta\u00efeb A et al (2023) Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm. J Eur Acad Dermatol Venereol 37:2173\u20132184. https:\/\/doi.org\/10.1111\/jdv.19451","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7749_CR19","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323:1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"JAMA"},{"issue":"Suppl 6","key":"7749_CR20","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay J, Upchurch KS (2012) ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatol Oxf Engl 51(Suppl 6):vi5-9. https:\/\/doi.org\/10.1093\/rheumatology\/kes279","journal-title":"Rheumatol Oxf Engl"},{"key":"7749_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R et al (2017) 2016 American college of rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76:9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571","journal-title":"Ann Rheum Dis"},{"key":"7749_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","volume":"81","author":"R Suppiah","year":"2022","unstructured":"Suppiah R, Robson JC, Grayson PC et al (2022) 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis 81:321\u2013326. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221796","journal-title":"Ann Rheum Dis"},{"key":"7749_CR23","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM et al (2010) EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798\u2013806. https:\/\/doi.org\/10.1136\/ard.2009.116657","journal-title":"Ann Rheum Dis"},{"key":"7749_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","volume":"48","author":"M Mosca","year":"2014","unstructured":"Mosca M, Tani C, Vagnani S et al (2014) The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 48:50\u201352. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.019","journal-title":"J Autoimmun"},{"key":"7749_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1249500","volume":"15","author":"L Balogh","year":"2024","unstructured":"Balogh L, Ol\u00e1h K, S\u00e1nta S et al (2024) Novel and potential future therapeutic options in systemic autoimmune diseases. Front Immunol 15:1249500. https:\/\/doi.org\/10.3389\/fimmu.2024.1249500","journal-title":"Front Immunol"},{"key":"7749_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10067-019-04880-z","volume":"39","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang Y, Bian W et al (2020) Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease. Clin Rheumatol 39:491\u2013497. https:\/\/doi.org\/10.1007\/s10067-019-04880-z","journal-title":"Clin Rheumatol"},{"key":"7749_CR27","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/1756-185X.13633","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang P, Gong Y, Liu Z et al (2019) Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: a prospective clinical trial. Int J Rheum Dis 22:1479\u20131488. https:\/\/doi.org\/10.1111\/1756-185X.13633","journal-title":"Int J Rheum Dis"},{"key":"7749_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/joim.13814","volume":"296","author":"Y Peng","year":"2024","unstructured":"Peng Y, Wang M, Sun R et al (2024) Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4-RD patients: a retrospective cohort study over a decade. J Intern Med 296:200\u2013212. https:\/\/doi.org\/10.1111\/joim.13814","journal-title":"J Intern Med"},{"key":"7749_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/CM9.0000000000002755","volume":"137","author":"L Peng","year":"2024","unstructured":"Peng L, Zhang X, Zhou J et al (2024) Comparison of clinical features and outcomes of proliferative, fibrotic, and mixed subtypes of IgG4-related disease: a retrospective cohort study. Chin Med J (Engl) 137:303\u2013311. https:\/\/doi.org\/10.1097\/CM9.0000000000002755","journal-title":"Chin Med J (Engl)"},{"key":"7749_CR30","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S2468-2667(24)00026-4","volume":"9","author":"J Akl","year":"2024","unstructured":"Akl J, Lee S, Ju HJ et al (2024) Estimating the burden of vitiligo: a systematic review and modelling study. Lancet Public Health 9:e386\u2013e396. https:\/\/doi.org\/10.1016\/S2468-2667(24)00026-4","journal-title":"Lancet Public Health"},{"key":"7749_CR31","unstructured":"Romero-G\u00f3mez C, Aguilar-Garc\u00eda JA, Garc\u00eda-de-Lucas MD et al (2015) Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies. Clin Exp Rheumatol 33:S-11\u201318"},{"key":"7749_CR32","first-page":"1","volume":"18","author":"J Zhang","year":"2020","unstructured":"Zhang J, Li Y, Sun X et al (2020) A retrospective investigation on the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis in a city, Southeast China. Guide China Med 18:1\u20135","journal-title":"Guide China Med"},{"key":"7749_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12026-024-09591-5","volume":"73","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Hong X, Neelagar R, Mo H (2025) Age-standardized incidence, prevalence, mortality rates and future projections of autoimmune diseases in China: a systematic analysis based on GBD 2021. Immunol Res 73:26. https:\/\/doi.org\/10.1007\/s12026-024-09591-5","journal-title":"Immunol Res"},{"key":"7749_CR34","doi-asserted-by":"publisher","first-page":"1020709","DOI":"10.3389\/fpubh.2022.1020709","volume":"10","author":"X Hu","year":"2022","unstructured":"Hu X, Chen Y, Shen Y et al (2022) Global prevalence and epidemiological trends of Hashimoto\u2019s thyroiditis in adults: a systematic review and meta-analysis. Front Public Health 10:1020709. https:\/\/doi.org\/10.3389\/fpubh.2022.1020709","journal-title":"Front Public Health"},{"key":"7749_CR35","first-page":"325","volume":"39","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang Z, Zheng J et al (2023) Prevalence of primary biliary cholangitis in the Chinese general population and its influencing factors: a systematic review. J Clin Hepatol 39:325\u2013332","journal-title":"J Clin Hepatol"},{"key":"7749_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11926-022-01079-1","volume":"24","author":"S Zhang","year":"2022","unstructured":"Zhang S, Peng L, Li Q et al (2022) Spectrum of spondyloarthritis among Chinese populations. Curr Rheumatol Rep 24:247\u2013258. https:\/\/doi.org\/10.1007\/s11926-022-01079-1","journal-title":"Curr Rheumatol Rep"},{"key":"7749_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.autrev.2014.01.049","volume":"13","author":"J-M Anaya","year":"2014","unstructured":"Anaya J-M (2014) The diagnosis and clinical significance of polyautoimmunity. Autoimmun Rev 13:423\u2013426. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.049","journal-title":"Autoimmun Rev"},{"key":"7749_CR38","doi-asserted-by":"publisher","first-page":"100187","DOI":"10.1016\/j.jtauto.2022.100187","volume":"6","author":"P Santos-Moreno","year":"2023","unstructured":"Santos-Moreno P, Arias-Aponte J, Rodr\u00edguez-Vargas G-S et al (2023) Polyautoimmunity in systemic lupus erythematosus patients: new insights from a cross-sectional study. J Transl Autoimmun 6:100187. https:\/\/doi.org\/10.1016\/j.jtauto.2022.100187","journal-title":"J Transl Autoimmun"},{"key":"7749_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/cen.14304","volume":"93","author":"A Botello","year":"2020","unstructured":"Botello A, Herr\u00e1n M, Salcedo V et al (2020) Prevalence of latent and overt polyautoimmunity in autoimmune thyroid disease: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 93:375\u2013389. https:\/\/doi.org\/10.1111\/cen.14304","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7749_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105848","volume":"90","author":"J Lopes","year":"2024","unstructured":"Lopes J, Fonte J, Costa A et al (2024) Polyautoimmunity and multiple autoimmune syndrome in patients with neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 90:105848. https:\/\/doi.org\/10.1016\/j.msard.2024.105848","journal-title":"Mult Scler Relat Disord"},{"key":"7749_CR41","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2665-9913(19)30006-2","volume":"1","author":"C Terao","year":"2019","unstructured":"Terao C, Ota M, Iwasaki T et al (2019) IgG4-related disease in the Japanese population: a genome-wide association study. Lancet Rheumatol 1:e14\u2013e22. https:\/\/doi.org\/10.1016\/S2665-9913(19)30006-2","journal-title":"Lancet Rheumatol"},{"key":"7749_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1826587","volume":"2020","author":"L-S Ji","year":"2020","unstructured":"Ji L-S, Sun X-H, Zhang X et al (2020) Mechanism of follicular helper T cell differentiation regulated by transcription factors. J Immunol Res 2020:1826587. https:\/\/doi.org\/10.1155\/2020\/1826587","journal-title":"J Immunol Res"},{"key":"7749_CR43","doi-asserted-by":"publisher","first-page":"i24","DOI":"10.1093\/rheumatology\/keaf008","volume":"64","author":"JH Stone","year":"2025","unstructured":"Stone JH (2025) Igg4-related disease: lessons from the first 20 years. Rheumatol Oxf Engl 64:i24\u2013i27. https:\/\/doi.org\/10.1093\/rheumatology\/keaf008","journal-title":"Rheumatol Oxf Engl"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07749-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:10:32Z","timestamp":1762881032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07749-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7749"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07749-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}